mofezolac has been researched along with Cholera Infantum in 2 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mofezolac (N-22) is a newly developed analgesic and anti-inflammatory agent." | 1.28 | Acute toxicity tests of mofezolac (N-22) in mice and rats. ( Ichiki, T; Kodama, R; Kuwasaki, E; Kuwata, M; Satoh, K; Sone, H; Yamamoto, N; Yamashita, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satoh, K | 2 |
| Yamamoto, N | 1 |
| Kuwasaki, E | 1 |
| Ichiki, T | 2 |
| Sone, H | 2 |
| Kodama, R | 2 |
| Kuwata, M | 2 |
| Yamashita, K | 2 |
| Furukawa, H | 1 |
| Nasu, Y | 1 |
2 other studies available for mofezolac and Cholera Infantum
| Article | Year |
|---|---|
Acute toxicity tests of mofezolac (N-22) in mice and rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Female; Gastroi | 1990 |
[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in rats].
Topics: Administration, Oral; Anemia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Fem | 1990 |